Daiwa Securities Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-360
| Closed | -$1K | – | 1331 |
|
|
2023
Q3 | $1K | Hold |
360
| – | – | ﹤0.01% | 1243 |
|
|
2023
Q2 | $2K | Hold |
360
| – | – | ﹤0.01% | 1221 |
|
|
2023
Q1 | $2K | Hold |
360
| – | – | ﹤0.01% | 1204 |
|
|
2022
Q4 | $4K | Hold |
360
| – | – | ﹤0.01% | 1159 |
|
|
2022
Q3 | $8K | Hold |
360
| – | – | ﹤0.01% | 1131 |
|
|
2022
Q2 | $9K | Buy |
360
+81
| +29% | +$2.03K | ﹤0.01% | 1135 |
|
|
2022
Q1 | $11K | Hold |
279
| – | – | ﹤0.01% | 1130 |
|
|
2021
Q4 | $16K | Sell |
279
-47
| -14% | -$2.7K | ﹤0.01% | 1122 |
|
|
2021
Q3 | $19K | Buy |
326
+140
| +75% | +$8.16K | ﹤0.01% | 1104 |
|
|
2021
Q2 | $16K | Hold |
186
| – | – | ﹤0.01% | 1022 |
|
|
2021
Q1 | $15K | Buy |
186
+22
| +13% | +$1.77K | ﹤0.01% | 1022 |
|
|
2020
Q4 | $15K | Sell |
164
-326
| -67% | -$29.8K | ﹤0.01% | 992 |
|
|
2020
Q3 | $20K | Buy |
490
+80
| +20% | +$3.27K | ﹤0.01% | 982 |
|
|
2020
Q2 | $9K | Hold |
410
| – | – | ﹤0.01% | 1058 |
|
|
2020
Q1 | $9K | Hold |
410
| – | – | ﹤0.01% | 1054 |
|
|
2019
Q4 | $8K | Hold |
410
| – | – | ﹤0.01% | 1071 |
|
|
2019
Q3 | $6K | Hold |
410
| – | – | ﹤0.01% | 1053 |
|
|
2019
Q2 | $8K | Hold |
410
| – | – | ﹤0.01% | 1049 |
|
|
2019
Q1 | $7K | Sell |
410
-140
| -25% | -$2.39K | ﹤0.01% | 1042 |
|
|
2018
Q4 | $7K | Buy |
+550
| New | +$7K | ﹤0.01% | 1017 |
|